Skip to content

Public FDA record

Z-0613-2024: Alinity ci-series System Control Module, REF: 03R70-01

Recall record Z-0613-2024 for Abbott Laboratories. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0613-2024
Company in FDA record
Abbott Laboratories
FDA classification date
Dec 22, 2023
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

There are potential performance issues found in the Alinity ci-series System software versions 3.4.0 and lower, including: 1) SCC Reagent load error during daily maintenance; 2) Sample Laboratory Report error; 3) Customer requests mechanism to prevent user error when creating new lots of value assigned Calibrators; 4) Error in processing tests after CCCintController encountered an error with the assay information downloaded from SCC; 5) The assay editor does not correctly check sample dilution total volume limits; 6) User-Applied Labels not adhering to Reagent Bottles; 7) ICT Module did not expire after warranty was exceeded. These performance issues could lead to erroneous results for multiple analytes.

Source facts

Action
On 5/30/23, correction notices were mailed to customers: -If code 5819 occurs, remove cartridges and onboard vial rack. Discard all cartridges and all samples in the onboard vial racks impacted by this issue. If a cartridge or onboard vial rack has fallen over inside the reagent carousel, contact Customer Service to clean any potential spill. -Avoid printing the Sample Laboratory report from the Sample Status Screen. If the Sample Laboratory report is printed verify the correct SID is printed on all pages. -When the barcode on the calibrator carton is scanned, only the master lot number and the expiration date are updated. The calibrator values remain from the previously configured master lot. To configure a new master lot for calibrators that have lot-specific calibrator values, the supervisor must verify that the correct values are entered and must edit them if necessary, or the supervisor must configure the master lot by importing the calibrator data. - Do not create a user defined assay with more than 40 Cuvette SmartWashes or 40 total reagent probe R1 and R2 SmartWashes. NOTE: The All setting can be used to replace individual reagent probe R1 or reagent probe R2 SmartWashes. Reagent probe settings that use the All setting need to be configured last. -Confirm for each user-defined assay that the sum of the configured sample volume + diluent volume + water volume is both greater than or equal to 80 micro L and less than or equal to 360 micro L -The label stock must meet the guidelines in 1D reagent barcode label requirements (c-series) in Section 4 of the Alinity ci-series Operations Manual and be compatible with Avery label templates 5520, L4773, or L7060. -If the ICT module status is exceeded with more than 20,000 samples processed, then confirm the expiration date of the ICT module before performing ICT assay testing. Complete and return the response form Questions can be directed to Customer Service at 1-877-4ABBOTT
Initiated
2023-05-30
Root cause
Software design
Distribution
US: AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, WA, WI, WV OUS: ALBANIA, ALGERIA, ARGENTINA, AUSTRALIA, AUSTRIA, BAHAMAS, BAHRAIN, BANGLADESH, BELARUS, BELGIUM, BERMUDA, BOSNIA AND HERZEGOVINA, BOTSWANA, BRAZIL, BRUNEI, BULGARIA, BURKINA FASO, CANADA, CAYMAN ISLANDS, CHILE, CHINA, COLOMBIA, COSTA RICA, CROATIA, CYPRUS, CZECH REPUBLIC, DENMARK, ECUADOR, EGYPT, EL SALVADOR, ESTONIA, ETHIOPIA, FAROE ISLANDS, FINLAND, FRANCE, , GAZA & JERICHO,GERMANY, GREECE, GREENLAND, GUATEMALA, HONDURAS, HONG KONG, HUNGARY, INDIA, INDONESIA, IRAN, IRELAND, ISRAEL, ITALY, JAMAICA, JAPAN, JORDAN, KAZAKHSTAN, KENYA, KOSOVO, KUWAIT, LATVIA, LEBANON, LITHUANIA, MACEDONIA, MADAGASCAR, MALAYSIA, MALDIVES, MAURITANIA, MAURITIUS, MEXICO, MOLDOVA, MONTENEGRO, MOROCCO, NAMIBIA, NETHERLANDS, NEW CALEDONIA, NEW ZEALAND, NICARAGUA, NORWAY, OMAN, PAKISTAN, PANAMA, PARAGUAY, PERU, PHILIPPINES, POLAND, PORTUGAL, QATAR, ROMANIA, RUSSIA, SAUDI ARABIA, SENEGAL, SERBIA, SINGAPORE, SLOVAKIA, SLOVENIA, SOUTH AFRICA, SOUTH KOREA, SPAIN, SWEDEN, SWITZERLAND, TAIWAN, THAILAND, TRINIDAD & TOBAGO, TUNISIA, TURKEY, UAE, UGANDA, UK, UKRAINE, URUGUAY, VIETNAM, ZAMBIA
Recall number
Z-0613-2024
Recall status
Open, Classified
CDRH record ID
204483
FDA classified
2023-12-22
Recall event number
93483

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗